O escândalo Epstein: um alerta para novas regras em doações acadêmicas

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Since December, when the US Department of Justice began releasing large batches of documents relating to the financier and convicted sex offender Jeffrey Epstein, details have steadily been emerging about his extensive ties to prominent scientists and research institutions. The default response of most in academia has been to say very little, in the hope of avoiding scrutiny, unless a clear connection to Epstein emerges. But the fact that an individual with no scientific expertise who was convicted of child sex abuse in 2008 was able to ingratiate himself deeply with academics and influence research for years points to a serious cultural failing. It demands honest reflection, not avoidance. Funding from individual donors: lessons from the Epstein case One ethical challenge raised by the Epstein scandal is how to address the conduct of those who befriended him, sought funding from him or responded to his requests for favours. In tackling this, transparency, due process and, when warranted, exclusion from conferences or dismissal from academic positions will be essential. The deeper lesson is unmistakable: faculty members must never be left to manage patron relationships without institutional oversight. There is nothing inherently wrong with cultivating relationships with potential donors. But many of Epstein’s associations that later proved problematic continued for much too long without supervisors, administrators or major-gift officers being informed. Researchers’ belated expressions of regret and claims of ‘nerd tunnel vision’ — that is, being too engrossed in research to notice warning signs — illustrate the hazards of allowing faculty members to manage donor relationships unchecked. Similarly, institutions must consider whether buildings, fellowships and awards should continue to use the names of benefactors who had ties to Epstein. There is a clear precedent: numerous museums and universities have removed the Sackler family name from galleries and programmes because of the family’s leadership of Purdue Pharma, the company behind OxyContin, a drug widely blamed for fuelling the US opioid epidemic. Major institutions, including the Solomon R. Guggenheim Museum in New York City and the British Museum in London, have renamed spaces that once carried the Sackler name. Scientists face fallout for past associations with Epstein But there is one question that has received far too little attention: how could this mess have happened? Why did Epstein’s overtures to scientists — and their willingness to engage with him — so often fail to arouse institutions’ concern, let alone trigger outright rejection? Around the world, many universities encourage individual faculty members to pursue private funding. However, academics are often naive when it comes to ensuring the appropriateness of donors, not least because the promotion system frequently rewards not caution, but the acquisition of major research funds. Nature 651, 283 (2026) doi: https://doi.org/10.1038/d41586-026-00698-3 Reprints and permissions The author declares no competing interests. Epstein files reveal deeper ties to scientists than previously known Philanthropic funders: team up to jump-start innovative science Pokémon turns 30 — how the fictional pocket monsters shaped science Smartphones are a double-edged tool in classrooms Correspondence 17 FEB 26 ‘I was nearly arrested’: escaping Myanmar’s military leadership for a PhD abroad What's the best way to change research fields? These three scientists have ideas Career Feature 25 FEB 26 Historically Black US universities chase top research ranking Career News 23 FEB 26 Why sky-high pay for AI researchers is bad for the future of science Under pressure: the reality of Mexico’s research system How a mathematician is cracking open Mexico’s powerful drug cartels Job Title:    Deputy Editor, Communications Medicine Location:    Shanghai, Beijing, Hybrid Working Model Application Deadline: Mar 26th, 2026   Ab... Shanghai, Beijing, Hybrid Working Model Seeking exceptional Senior/Junior PIs, Postdocs, and Core Specialists globally year-round Hangzhou Institute of Medicine Chinese Academy of Sciences (HIMCAS) Join HZAU's global faculty team to advance research with competitive benefits. No.1 Shizishan Street, Hongshan District, Wuhan, Hubei Province, China Huazhong Agricultural University (HZAU) Postdoctoral fellow positions are available Robert Wood Johnson Medical School - Department of Neurosurgery The Medical Faculty Mannheim of Heidelberg University offers the position of a   Full professorship (W3) for “Transfusion Medicine and Immunology” ... Mannheim, Baden-Württemberg (DE) Medizinische Fakultät Mannheim der Universität Heidelberg Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.